Enzymotec Announces Pricing of Its Initial Public Offering

Published: Sep 27, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MIGDAL HA'EMEQ, Israel, Sept. 26, 2013 (GLOBE NEWSWIRE) -- Enzymotec Ltd. today announced the pricing of its initial public offering of 4,412,000 ordinary shares at a price of $14.00 per share. In addition, the underwriters have been granted a 30-day option to purchase up to an additional 661,800 ordinary shares from the Company at the initial public offering price.

Help employers find you! Check out all the jobs and post your resume.

Back to news